| Category | BioTech |
| Phone | 33-1-60-87-54-60 |
| Employees | |
| Founded | 1999 |
| TOTAL | $20.8M |
| FUNDING TOTAL | $20.8M |
| Venture Round, 3/05 Auriga Partners Matignon Investissement & Gestion Edmond de Rothschild Venture Capital 123Venture | €7.25M |
| Venture Round, 4/07 Creabilis Rothschild Gestion Auriga Partners Matignon Investissement & Gestion 123Venture | $11.3M |
Nautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company’s products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company’s protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.
